Systemic Therapies for AD
Explore the evolving landscape of systemic therapies for atopic dermatitis, highlighting the factors influencing treatment decisions. From traditional immunosuppressants to cutting-edge biologics and JAK inhibitors, this talk provides insights into their benefits, risks, and considerations for individualized care.
Joy Wan, MD, MSCE, FAAD, is an assistant professor of dermatology in the department of dermatology at the Johns Hopkins University School of Medicine in Baltimore, MD.
Please note: An additional systemic therapy has been approved for atopic dermatitis since the conference presentation in this video. Visit https://www.hmpgloballearningnetwork.com/site/thederm/fda-alerts/lebrikizumab-fda-approved-moderate-severe-atopic-dermatitis-adults-and for more information.
© 2025 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates.
The APP Institute is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of patient care across the spectrum of dermatology.
The APP Institute | Dermatology is designed for Advanced Practice Providers who specialize in Dermatology, to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods, while remaining focused on the fundamental principles and terminology associated with Dermatology. Engage year-round with the Dermatology Learning Network to access clinical insights, interactive features, research news updates, accredited continuing education programs, and more.
